Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.
- DOI
- 10.1002/gcc.23133
- Published
- 2023 Jun
- Container
- Genes, chromosomes & cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/gcc.23133,
title = {Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.},
author = {Wills C and Watts K and Maughan TS and Fisher D and Al-Tassan NA and Houlston RS and Escott-Price V and Cheadle JP},
year = {2023},
journal = {Genes, chromosomes \& cancer},
doi = {10.1002/gcc.23133},
url = {https://doi.org/10.1002/gcc.23133}
}RIS
TY - JOUR TI - Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer. AU - Wills C AU - Watts K AU - Maughan TS AU - Fisher D AU - Al-Tassan NA AU - Houlston RS AU - Escott-Price V AU - Cheadle JP PY - 2023 JO - Genes, chromosomes & cancer DO - 10.1002/gcc.23133 UR - https://doi.org/10.1002/gcc.23133 ER -
APA
C, W., K, W., TS, M., D, F., NA, A., RS, H., V, E., & JP, C. (2023). Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.. Genes, chromosomes & cancer. https://doi.org/10.1002/gcc.23133
Source records
- pubmed · retrieved 2026-09-27T15:49:40.640Z